Eisai
4523.T
#2184
Rank
A$12.76 B
Marketcap
A$45.23
Share price
0.11%
Change (1 day)
-1.03%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total debt

Total debt on the balance sheet as of September 2025 : A$2.41 Billion

According to Eisai's latest financial reports the company's total debt is A$2.41 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Eisai - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2025-03-31A$2.00 B24.35%
2024-03-31A$1.61 B14.14%
2023-03-31A$1.41 B35.74%
2022-03-31A$1.04 B-2.67%
2021-03-31A$1.06 B-21.59%
2020-03-31A$1.36 B-22.51%
2019-03-31A$1.75 B-17.01%
2018-03-31A$2.11 B-15.52%
2017-03-31A$2.50 B6.33%
2016-03-31A$2.35 B-8.65%
2015-03-31A$2.58 B-0.03%
2014-03-31A$2.58 B-19.21%
2013-03-31A$3.19 B-20.31%
2012-03-31A$4.01 B-8.97%
2011-03-31A$4.40 B-7.03%
2010-03-31A$4.74 B-22.43%
2009-03-31A$6.11 B39.22%
2008-03-31A$4.39 B176969.31%
2007-03-31A$2.48 M-50.06%
2006-03-31A$4.96 M-50.45%
2005-03-31A$10.02 M310.24%
2004-03-31A$2.44 M396.1%
2003-03-31A$0.49 M-99.46%
2002-03-31A$91.9 M-28.95%
2001-03-31A$0.12 B-54.66%
2000-03-31A$0.28 B